Stephen Doster
-
Vanderbilt joins Wellcome Leap global network dedicated to accelerating breakthroughs in human health
by Marissa Shapiro Jan. 28, 2021, 7:00 AM Vanderbilt University has joined the Leap Health Breakthrough Network, a global group of leading academic and research institutions committed to solving the world’s most serious health challenges—such as cancer and infectious diseases—at record speed. Wellcome Leap is… Read MoreJan. 28, 2021
-
A protein that can melt tumors discovered at Vanderbilt
by Marissa Shapiro Jan. 27, 2021, 9:00 AM For the second time, cancer researchers at Vanderbilt have discovered a protein that—when genetically manipulated to impede it from interacting with a gene responsible for cancer genesis—effectively melts tumors in days. The article, “MYC regulates ribosome… Read MoreJan. 28, 2021
-
Inflammation in genetic epilepsy
Jan. 21, 2021, 11:00 AM by Leigh MacMillan Brain inflammation plays a role in human epilepsy, but most studies have focused on acquired epilepsies, such as those due to head trauma, viral infection or other insults. Neuroinflammation has never been reported in genetic epilepsy associated with ion channel gene mutations. … Read MoreJan. 28, 2021
-
Newly discovered molecule disrupts virus infections through protein quality control pathways
by Marissa Shapiro Jan. 26, 2021, 9:00 AM A chemical probe molecule—a “first gen” molecule that can be used for drug development—that targets a host cell’s protein quality control pathways can dramatically reduce infection by Dengue and Zika viruses. The research led by Lars… Read MoreJan. 27, 2021
-
WIN for blocking cancer growth
Jan. 21, 2021, 10:00 AM by Sarah Glass WDR5 is a protein that is overexpressed in a variety of cancers. Inhibiting WDR5 by targeting the WDR5-interaction (WIN) site can inhibit the growth of cancer cells in vitro, but this mechanism of action has not been fully elucidated. Publishing in … Read MoreJan. 22, 2021
-
Early research shows promise for therapeutics that delay Type 2 Diabetes
by Marissa Shapiro Jan. 12, 2021, 9:00 AM Vanderbilt researchers have discovered a unique pathway that initiates islet β cell inflammation—a hallmark of type 2 diabetes—putting them a step closer to developing targeted therapeutics for the disease that affects one in 10 Americans. Wenbiao… Read MoreJan. 13, 2021
-
Borden Lacy named director of Vanderbilt’s Center for Structural Biology
by Marissa Shapiro Jan. 11, 2021, 9:00 AM Borden Lacy (Vanderbilt University) Borden Lacy, Edward and Nancy Fody Chair in Pathology and professor of biochemistry and pathology, microbiology and immunology, has been named director of the Vanderbilt Center for Structural Biology. She… Read MoreJan. 11, 2021
-
Siciliano named to 2021 ‘Forbes’ 30 under 30
by Marissa Shapiro Jan. 8, 2021, 9:06 AM Vanderbilt alumnus Graham Gaylor and Assistant Professor of Pharmacology Cody Siciliano have been selected for the 2021 Forbes “30 Under 30.” The 10th annual list recognizes 600 entrepreneurs, scientists, activists and entertainers changing the world. Graham… Read MoreJan. 8, 2021
-
Genome editing technique “rescues” mice from accelerated aging disorder: study
Jan. 6, 2021, 10:31 AM by Bill Snyder Researchers from the Broad Institute of Harvard and MIT, the National Institutes of Health (NIH) and Vanderbilt University Medical Center for the first time have used a novel genome-editing technique to “rescue” mice from progeria, a rare genetic disease that causes accelerated… Read MoreJan. 7, 2021
-
Vanderbilt researchers take leadership role in COVID-19 vaccine development
by Marissa Shapiro Dec. 18, 2020, 11:55 AM Work on COVID-19 theraputics at Vanderbilt University Medical Center (VUMC) As the United States and the rest of the world witness the rollout of new vaccines targeting COVID-19—as well as better treatment options to fight the… Read MoreDec. 18, 2020